252 related articles for article (PubMed ID: 36821458)
21. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
[TBL] [Abstract][Full Text] [Related]
22. Probiotic agents in the treatment of irritable bowel syndrome.
Guslandi M
J Int Med Res; 2007; 35(5):583-9. PubMed ID: 17900396
[TBL] [Abstract][Full Text] [Related]
23. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
Cash BD
Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
[TBL] [Abstract][Full Text] [Related]
24. Probiotics in luminal gastroenterology: the current state of play.
Andrews JM; Tan M
Intern Med J; 2012 Dec; 42(12):1287-91. PubMed ID: 23252997
[TBL] [Abstract][Full Text] [Related]
25. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
26. Probiotics for the treatment of inflammatory bowel disease.
Veerappan GR; Betteridge J; Young PE
Curr Gastroenterol Rep; 2012 Aug; 14(4):324-33. PubMed ID: 22581276
[TBL] [Abstract][Full Text] [Related]
27. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
Szilagyi A; Xue X
Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
[TBL] [Abstract][Full Text] [Related]
28. The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review.
Zhang T; Zhang J; Duan L
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049407
[TBL] [Abstract][Full Text] [Related]
29. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
30. Probiotics use to treat irritable bowel syndrome.
Hosseini A; Nikfar S; Abdollahi M
Expert Opin Biol Ther; 2012 Oct; 12(10):1323-34. PubMed ID: 22897430
[TBL] [Abstract][Full Text] [Related]
31. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
Moraes-Filho JP; Quigley EM
Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477
[TBL] [Abstract][Full Text] [Related]
32. Antibiotics and probiotics in treatment of inflammatory bowel disease.
Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
[TBL] [Abstract][Full Text] [Related]
33. Is irritable bowel syndrome an infectious disease?
Thompson JR
World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
[TBL] [Abstract][Full Text] [Related]
34. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews.
Whelan K
Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):581-7. PubMed ID: 21892075
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of probiotics in inflammatory bowel disease.
Cain AM; Karpa KD
Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
[TBL] [Abstract][Full Text] [Related]
37. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
[TBL] [Abstract][Full Text] [Related]
38. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
[TBL] [Abstract][Full Text] [Related]
39. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
40. Relevance and needs of irritable bowel syndrome (IBS): Comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.).
Mearin F; Sans M; Balboa A
Gastroenterol Hepatol; 2022 Dec; 45(10):789-798. PubMed ID: 35051542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
